Results 1 to 10 of about 19,061 (206)
Macedonian Journal of Medical Sciences, 2013 Aim: The aim of this review was to provide an overview of the terminology, technology and methodology of pharmacoeconomic evaluations. The choice is made because there is small number of reviews on this subject in Macedonia, and also because of the subject actuality.Methods: There are four common types of methods of cost-outcomes economic evaluations ...
Marc A. Darst +2 more
+7 more sources
Pharmacy, 2023 For the improvement of access to health, many countries including South Africa, have adopted universal healthcare. However, this requires skills to apply health technology assessments for the facilitation of investment decisions.
Carlien Schmidt +4 more
doaj +1 more source
YAKUGAKU ZASSHI, 2003 AbstractFor Abstract see ChemInform Abstract in Full Text.
Joseph Heyse +2 more
+6 more sources
Scientific Reports, 2022 The purpose of this work was to review and synthesise the evidence on the comparative effectiveness of neutralising monoclonal antibody (nMAB) therapies in individuals exposed to or infected with SARS-CoV-2 and at high risk of developing severe COVID-19.
David McConnell +6 more
doaj +1 more source
Cost analysis of the use of botulinum toxin type A in Spain [PDF]
Farmacia Hospitalaria, 2014 Objective: To estimate treatment costs of blepharospasm, cervical dystonia(CD), upper limb spasticity (ULS) and spasticity in children withcerebral palsy (SCCP) with botulinum neurotoxin type A (BoNT-A) inSpain.
F. de Andrés-Nogales +5 more
doaj +1 more source
BMC Public Health, 2023 Background Non-pharmacological interventions (NPIs) could be considered in the early management of prehypertensive population. This study aimed to evaluate the potential cost-effectiveness of NPIs and the budget impact of implementing NPIs on ...
Leyi Liang +4 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Objective: After Gemstone-302 was published in Lancet in January 2022, seven PD-(L)1 inhibitors launched or about to be launched in China, but there are no head-to-head RCTs reporting the comparative efficacy for squamous non-small cell lung cancer (sq ...
Mingye Zhao +8 more
doaj +1 more source
PHARMACOECONOMICS AS A TOOL TO ENHANCE EFFICENCY OF HEALTH CARE SERVICES
Ринкова економіка: сучасна теорія і практика управління, 2017 Pharmacoeconomics identifies, measures, and compares the costs and consequences of drug therapy to health care systems and society. This article discusses the principles and methods of pharmacoeconomics and how they can be applied to clinical pharmacy ...
Denys Zakrytov, Navneet Kaur
doaj +1 more source
A survey of pharmacists' knowledge, attitudes and barriers in pharmaceutical care concept in Poland
BMC Medical Education, 2021 Background The major goals of pharmaceutical care (PC) are to improve the patient’s quality of life and ensure safety of pharmacotherapy. Inclusion of a pharmacist in the multidisciplinary team caring for the patient and integration of state-of-the-art ...
Dorota Kopciuch +5 more
doaj +1 more source
Knowledge, Attitude, and Practices of Moroccan Retail Pharmacists towards Veterinary Medicines
Advances in Pharmacological and Pharmaceutical Sciences, 2022 This is the first study conducted in Morocco to assess knowledge, attitude, and practices of retail pharmacists regarding veterinary medicines. It is a cross-sectional study.
Zeinab Snoussi, Samir Ahid
doaj +1 more source